Program

7:00 AM – 6:00 PM

Registration Open

7:30 AM – 5:00 PM

Endocrine Neck Advanced Ultrasound Course (Additional Registration Required)

8:00 AM – 2:00 PM

ATA Board of Directors Meeting (Invite Only)

8:00 AM – 5:00 PM

E. Chester Ridgway Trainee Conference (Additional Registration Required)

7:45 AM – 4:30 PM

Leadership Development Workshop (Additional Registration Required)

8:00 AM – 5:00 PM

Introduction to Interventional Endocrinology Course (Additional Registration Required)

2:00 PM – 6:00 PM

ATA Committee/Guidelines/Task Force Meetings

7:15 AM – 6:30 PM

Registration Open

7:30 AM – 8:00 AM

Opening Remarks – President and Meeting Co-Chairs

• Michael McDermott – MD, President
• Whitney Goldner, MD – Program Committee Co-Chair
• Meredith Hartley, PhD – Program Committee Co-Chair

8:00 AM – 9:00 AM

Year in Thyroidology

• Whitney Goldner, MD – Co-Chair
• Meredith Hartley, PhD – Co-Chair
• Douglas Forrest, PhD – Basic Science Year in Review
• Jennifer Sipos, MD – Clinical Science Year in Review
• Elizabeth Gardner Grubbs, MD – Surgical Year in Review

9:10 AM – 10:10 AM

Oral Abstracts

• Basic – Thyroid Hormone Action & Regulation
  • Ziyu Zhu, PhD(C) – Co-Chair
  • Steffen Mayerl, PhD – Co-Chair
    • Robert Opitz, PhD – Thyroid hormone promotes upper layer neuron specification in human cerebral organoids
    • Xiaohan Zhang, MD, PhD – Hypothyroidism with Defective Thyroglobulin Co-opts the Machinery of Thyroid Hormone Synthesis to Drive Thyroid Cell Death
    • Alexandra M. Dumitrescu, MD, PhD – Severe osteoporotic phenotype in Secisbp2 deficient mice
    • Xiaohan Zhang, MD, PhD – Thyroidal Function of the Endoplasmic Reticulum Molecular Chaperone, GRP170
• Technology & Thyroid
  • Johnson Thomas, MD – Co-Chair
  • Benjamin Gigliotti, MD – Co-Chair
    • Esteban Andres Cabezas Rubio, MD – ChatGPT-4’s Accuracy in Estimating Thyroid Nodule Cancer Risk from Ultrasound Images
    • Chutintorn Sriphrapradang, MD – Artificial Intelligence-Enhanced Infrared Thermography as a Diagnostic Tool for Thyroid Malignancy Detection
    • Stefano Spiezia, MD – Clinical Feasibility Study using Nanosecond Pulsed Field Ablation (nsPFA) to Treat Benign Thyroid Nodules
    • Nikita Pozdeyev, MD, PhD – Hereditary Thyroid Cancer in the United States Population
• Clinical – Thyroid Cancer
  • Victor Bernet, MD – Co-Chair
  • Nazanene Esfandiari, MD – Co-Chair
    • Steven G. Waguespack, MD – Efficacy, Safety, and Genomic Data in Patients With TRK Fusion Thyroid Carcinoma (TC) Treated With Larotrectinib
    • Juan P. Brito Campana, MD – GLP-1RA Use and Thyroid Cancer Risk: Retrospective Emulation of a Target Trial
    • Julien Hadoux, MD, PhD – Efficacy of Selpercatinib by RET mutation in RET-mutant Medullary Thyroid Cancer: A combined analysis of LIBRETTO-001 and LIBRETTO-531 trials
    • Sapir Nachum Goldberg, MD – Thyroid Nodules with Indeterminate Cytology and Negative Molecular Testing: Prevalence of Malignancy and Practice Paradigms for Surveillance

5:30 PM – 6:30 PM

Bobbi Smith Networking Social: Halloween Happy Hour

7:15 AM – 5:00 PM

Registration Open

7:45 AM – 8:00 AM

Recognition of Stanbury Medal, Distinguished Service Award, Women In Thyroidology Award, and Morning Announcements from Co-Chairs

• Michael T. McDermott, MD – Chair
• Whitney Goldner, MD – Program Committee Co-Chair
• Meredith Hartley, PhD – Program Committee Co-Chair
• Stephen LaFranchi, MD – John B. Stanbury Thyroid Pathophysiology Medal
• Elizabeth N. Pearce, MD – Distinguished Service Award
• Anne R. Cappola, MD – Women In Thyroidology Award

8:00 AM – 9:00 AM

Galton & Ingbar Award Recognition & Lectures

• Chris J. McCabe, PhD – Chair and Moderator
• Jacqueline Jonklaas, MD, PhD – Introduction
• Anna M. Sawka, MD, PhD – Galton Lecture
• Paul W. Ladenson, MD – Introduction
• Mingzhao Xing, MD, PhD – Ingbar Lecture

5:15 PM – 6:15 PM

Sawin Lecture

• Kenneth Burman, MD – Chair
• Angela M. Leung, MD, MSc – Landmark Discoveries in Maternal-Fetal Thyroid Disease Over the Past Century

6:20 PM – 7:00 PM

Membership Meeting

• Chris J. McCabe, PhD – Chair, ATA Secretary
• Michael T. McDermott, MD – ATA President
• Anthony N. Hollenberg, MD – ATA Treasurer

7:45 AM – 5:00 PM

Registration Open

8:05 AM – 9:05AM

Parallel Sessions

• Retiring the Words Burnout and Resiliency – Virtual Speaker (Planned by Women in Thyroidology)
  • Naifa Lamki Busaidy, MD – Chair
  • Hala Sabry DO, MBA
• Beyond the Scar: Navigating Fertility, Bone and Cardiac Health in Thyroid Cancer Survivors
  • Kristien Boelaert, MD, PhD – Co-Chair
  • Kaniksha Shekhar Desai, MD – Co-Chair
  • Rima Dhillon-Smith, MB ChB, PhD – Fertility
  • Megan R. Haymart, MD – Bone health
  • Anna M. Sawka, MD, PhD – Cardiovascular health
• Meet the Professor: Insights into Thyroid Disease: Tapping into Single-Cell & Spatial ‘Omics
  • Meredith D. Hartley, PhD – Chair
  • Melissa Genevieve Lechner, MD, PhD
  • Jarod Olay, MS
• Oral Abstract Session: Autoimmunity, Thyroid Nodules & Goiter (No CME)
  • J. Woody Sistrunk, MD – Chair
    
  • Kyubo Shin, PhD – Validation of Glandy CASTM Software as Medical Device for Thyroid Eye Disease Activity Assessment: A Confirmatory Clinical Trial for Ministry of Food and Drug Safety Approval
  • Marcos Santos, PhD – Enhanced performance of the new optimized version (v2) of the microRNA and DNA-based molecular classifier test: Insights from a Latin American Multicenter Study
  • Joonhyeon Park, PhD – Glandy EXO : A Deep Learning Approach for Proptosis Measurement in Thyroid Eye Disease

9:15AM – 10:15AM

Parallel Sessions

• Molecular Testing and its Role in Personalized Management of Thyroid Cancer
  • Mayumi Endo, MD – Chair
  • Rossella Elisei, MD – Dissecting the role of fusions in thyroid cancer (DTC and MTC)
  • Matti Lauren Gild, MBBS – Prognostic implications of other mutations besides fusions in patients with thyroid cancer
  • Ali Alzahrani, MD – Molecular testing at different stages of thyroid cancer management
• Thyroid Hormone and Metabolism
  • Sheue-yann Cheng, PhD – Co-Chair
  • Tatiana L. Fonseca, PhD – Co-Chair
  • Megan Jean Ritter, MD – Thyroid hormone coregulator and liver metabolism
  • Hao Ying, PhD – Thyroid hormone regulation of adipocyte development
  • Madhulika Tripathi, PhD – Thyroid hormone ameliorates the metabolic actions of fructose in MASH
• Concerns and Obstacles to AI Adoption in Thyroidology
  • Franklin Neil Tessler, MD – Co-Chair
  • David Toro-Tobon, MD – Co-Chair
  • Nikita Pozdeyev, MD, PhD – Data quality, performance, trust and reliability
  • Naykky Maruquel Singh Ospina, MD – Regulatory, safety and privacy concerns
  • Juan P. Brito Campana, MD – Access, knowledge and training/Workforce and Job Security

2:10 PM – 3:10 PM

Parallel Sessions

• Thyroid Dialogues: Artificial Intelligence in Scientific Publishing
  • Anna M. Sawka, MD, PhD – Co-Chair
  • Julie Ann Sosa, MD – Co-Chair
  • Sonja Krane, PhD – Publishing perspective on manuscript submissions & review
  • Melissa Kacena, PhD – AI & manuscript development
  • Peter Angelos, MD, PhD – Ethical considerations
• Putting into Practice New Pathologic Entities 2023 Bethesda and 2022 WHO: Insightful Case Presentations
  • Sarah L. Rhode, MD – Chair
  • Zubair W. Baloch, MD, PhD – Changes to the 2023 Bethesda and WHO 2022 Systems
  • Justine Barletta, MD – Low-risk thyroid lesions of uncertain malignant potential
  • Fernanda Vaisman, MD, PhD – Case Presentation: Putting new pathologic diagnoses into clinical practice
• Neoadjuvant Therapy for Thyroid Cancer
  • Sarimar N. Agosto Salgado, MD – Co-Chair
  • Ramona Dadu, MD – Co-Chair
  • Richard J. Wong, MD, FACS – Application of a neoadjuvant approach from a surgical perspective: Selecting best candidates, assessing response & intraoperative challenges
  • Bhavana Konda, MD – Systemic therapies in the neoadjuvant setting: Insights from a medical oncologist’s perspective
  • Mark Zafereo, MD – Neoadjuvant clinical trials: What is the evidence so far?

3:15 PM – 4:15PM

Oral Abstracts

Surgical Issues in Thyroidology

• Sophie Dream, MD – Co-Chair
• Marika Russell, MD – Co-Chair
• Emily Ajit-Roger – Factors Increasing the Likelihood of Postoperative Hematomas Following Thyroid Surgery
• Caitlin T. Yeo, MD – Prospective Implementation of Thyroid Lobectomy Guidelines and Preoperative ThyroSPEC Molecular Testing: Impact on Rates of Lobectomy and Completion Thyroidectomy
• Anthony Saxton, MD – Patient-Reported Outcomes after Thyroid Surgery for Differentiated Thyroid Cancer: A Crucial Consideration for Personalized Treatment Decisions
• Dana Hamadi, MBBS – The Utilization of Radiofrequency Ablation in the Management of Thyroid Nodules and Factors Influencing its Efficacy

Basic & Translational – Thyroid Cancer

• Athanasios Bikas, MD, PhD – Co-Chair
• Vicki Smith, PhD- Co-Chair
• Antonio Di Cristofano, PhD – Characterization and targeting of synthetic lethal vulnerabilities uncovered by inhibition of one carbon metabolism in anaplastic thyroid cancer
• Sarah Hamidi, MD – Integrated Genomic Analysis Identifies Tumor Differentiation Status as a Crucial Determinant of Immune Infiltration and Potential Combinatorial Therapeutic Targets with Immunotherapy in Papillary Thyroid Carcinoma Patients
• Maaike Van Gerwen, MD, PhD – Metabolomic pathways associated with timing to thyroid cancer diagnosis
• Shiyu Yuan, PhD – Anaplastic Thyroid Cancer Bone Metastasis: Mechanistic Insight From Mouse Models

Thyroid Nodules & Cancer

• Siobhan Pittock, MB, ChB- Co-Chair
• Amanda La Greca, MD – Co-Chair
• Ralf Paschke, MD – Development of a nomogram—a visually intuitive tool—that illustrates the contribution of molecular testing in addition to all diagnostic components in an optimized integrated interdisciplinary thyroid nodule diagnostic pathway facilitating integrated mali
• Peiling Samantha Yang, MBBS – Re-differentiation Therapy Clinical Trial Using Dabrafenib & Trametinib in RAI-Refractory BRAF/RAS-Mutant Thyroid Cancer Applying a Novel Time-Dependent Concept
• Trisha Dee Cubb, MD – Effect of PI3K Pathway Activating Mutations (PI3Kpath-mutation) on Response to BRAF/MEK Inhibitor (BRAF/MEKi) Therapy in BRAFV600E Mutated Anaplastic Thyroid Cancer (BRAFV600Em-ATC)
  Maria E. Cabanillas, MD – Adjuvant pembrolizumab (pembro) after multimodal therapy for anaplastic thyroid cancer (ATC)

4:30 PM – 5:45 PM

Parallel Sessions

• Guidelines Update: Differentiated Thyroid Cancer
  • R. Michael Tuttle, MD – Chair
  • Julie Ann Sosa, MD
  • Matthew D. Ringel, MD
• Translational Insights in Thyroid Hormone Resistance due to Mutations in TRalpha
  • W. Edward Visser, MD – Co-Chair
  • Karn Wejaphikul, MD, PhD – Co-Chair
  • Marcel Meima, PhD – Molecular mechanisms underlying neurocognitive variability in RTHa
  • Luca Persani, MD, PhD – Expression of mutant TRalpha in zebrafish embryos
  • Vengalil Krishna Chatterjee, MD – Diagnosis and clinical management of RTHalpha

6:00 PM – 8:00 PM

Dinner on your own

8:00 AM – 11:00 AM

Registration Open

8:15 AM – 9:30 AM

Parallel Sessions

• Guidelines Update: Thyroid & Pregnancy
  • Spyridoula Maraka, MD – Chair
  • Angela M. Leung, MD, MSc
  • Tim Korevaar, MD, PhD
• Thyroid Hormone Regulation of Stem Cells in Diverse Organ Systems
  • Soledad Barez Lopez, PhD – Co-Chair
  • Thomas S. Scanlan, PhD – Co-Chair
  • Michelina Plateroti, PhD – Impact of the Thyroid hormone nuclear Receptor TRa1 in intestinal stem cells physiopathology
  • Sylvie Remaud, PhD – Long-term functional consequences on neurogliogenesis of perinatal modulation of thyroid hormone action
  • Jeff Huang, PhD – How does thyroid hormone influence the cell fate of adrenocortical cells?

9:45 AM – 11:00 AM

Parallel Sessions

• Tumor Board
  • David C. Shonka, MD – Co-Chair
  • Sarah Emily Mayson, MD – Co-Chair
  • Sara Ahmadi, MD
  • Nicole Massoll, MD
  • Francis Worden, MD
  • Michael W. Yeh, MD
• Basic Models and Translational Studies: Pathogenesis of Autoimmune Thyroid Disease
  • Gregory A. Brent, MD – Co-Chair
  • Vivian Lee Weiss, MD, PhD – Co-Chair
  • Michelle Rengarajan, MD, PhD
  • Daham Kim, MD, PhD – Mouse models for investigating Graves’ Disease and associated orbitopathy
  • Fabiana Pani, MD – Thyroid autoimmunity and thyroid cancer: biological and translational insights from a new mouse model